B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy targets hard-to-treat blood cancers after other options fail
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy called Sup19 in 9 adults with B-cell blood cancers (like leukemia or lymphoma) that either stopped responding to previous CD19-targeted treatments or have low levels of the CD19 protein. The main goal is to check safet…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 04:11 UTC
-
New immune cell therapy targets tough blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new treatment called BAFFR CAR-T for people with B-cell tumors that have come back or not responded to other therapies. The study will enroll 12 adults aged 18-85 to check the therapy's safety and find the right dose. The approach uses a patient's o…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC